Managing Antiplatelet Therapy in Patients with Acute Coronary Syndrome

Published Online: Monday, March 25, 2013
In this podcast, Toby Trujillo, PharmD, BCPS, an associate professor at the University of Colorado Denver School of Pharmacy, discusses issues related to options for managing antiplatelet therapy in patients with acute coronary syndrome. To listen to the podcast, click here.
Related Articles
A recent study examines the comparative efficacy of prasugrel and clopidogrel in the treatment of patients who underwent percutaneous coronary intervention.
Patients who were treated for persistent depression after an acute coronary syndrome experienced improved outcomes during treatment, but worsened outcomes after treatment ended.
An analysis of 2 randomized trials of statin therapy for patients enrolled after an acute coronary syndrome finds that high-dose statins do not increase the risk of kidney injury.
The Target: Stroke initiative reduced the time before acute ischemic stroke patients were treated with intravenous tissue plasminogen activator, leading to reduced rates of in-hospital mortality and intracranial hemorrhage.
Latest Issues
$auto_registration$